Related Experiment Videos
Case report: extra pulmonary tuberculosis in sickle cell disease.
A O Kehinde1, J A Olaniyi, E E Fakunle
1Tuberculosis Research Laboratory, Department of Medical Microbiology and Parasitology, College of Medicine, University College Hospital, Ibadan, Nigeria. aokehinde@yahoo.com
African Journal of Medicine and Medical Sciences
|February 23, 2007
Summary
Extra-pulmonary tuberculosis (EPTB) in a sickle cell anaemia patient presented with hip pain and neurological deficits. Early diagnosis and treatment of EPTB are crucial, especially in immunocompromised individuals.
Area of Science:
- Medicine
- Infectious Diseases
- Immunology
Background:
- Tuberculosis (TB) typically affects the lungs but can manifest as extra-pulmonary tuberculosis (EPTB) in individuals with compromised immune systems.
- Sickle cell anaemia (HBS) is a known risk factor for various infections, potentially increasing susceptibility to EPTB.
Observation:
- A 22-year-old female with HBS presented with a three-month history of bilateral hip pain, weight loss, left hip swelling with discharging sinuses, paraplegia, and recurrent fever.
- Initial investigations revealed leukocytosis, thrombocytosis, elevated ESR (120mm/Hr), and normal retroviral screening. Acid-fast bacilli (AFB) smears were negative.
- Pelvic X-ray showed L4/L5 disc space loss and avascular necrosis of the femoral heads, while chest X-ray was normal.
Findings:
- Bacteriologic cultures from sinuses grew Escherichia coli and Staphylococcus aureus, sensitive to sparfloxacin.
- Despite negative AFB smears, the patient's clinical and hematological parameters improved on an anti-TB regimen, indicating a diagnosis of EPTB.
- A nine-month course of anti-TB therapy was completed, followed by discharge to physiotherapy.
Implications:
- This case underscores the importance of a high index of clinical suspicion for EPTB in patients with underlying conditions like HBS.
- Diagnostic challenges highlight the need for advanced laboratory facilities to accurately diagnose EPTB, particularly when initial smears are negative.
- Effective management of EPTB requires prompt diagnosis and appropriate anti-TB therapy, emphasizing the critical role of well-equipped diagnostic services.
Related Concept Videos
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.